damage or from errors committed during DNA synthesis. In There is increasing evidence that in eukaryotic cells, DNA this review we will consider the generation of mutations in undergoes continuous damage, repair and resynthesis. A human cells, the multiplicity of mutations present in human homeostatic equilibrium exists in which extensive DNA tumors, and the relationship of multiple mutations to tumor damage is counterbalanced by multiple pathways for DNA progression. Recent studies have suggested two pre-eminent repair. In normal cells, most DNA damage is repaired mechanisms for the generation of mutations in cancer cells, without error. However, in tumor cells this equilibrium one involving deficits in DNA repair and one involving deficits may be skewed, resulting in the accumulation of multiple in chromosomal partitioning during cell division. We will mutations. Among genes mutated are those that function consider the hypothesis that there are thousands of mutations in guaranteeing the stability of the genome. Loss of this in cancer cells and that there are many mechanisms for the stability results in a mutator phenotype. Evidence for a generation of a mutator phenotype in cancer cells. mutator phenotype in human cancers includes the frequent occurrence of gene amplification, microsatellite instability, Mutations result from DNA damage chromosomal aberrations and aneuploidy. Current experiIt has become increasingly recognized that, rather than being ments have centered on two mechanisms for the generation inert, cellular DNA undergoes continuous damage and resynof genomic instability, one focused on mutations in misthesis. DNA is damaged by both environmental and cellular match repair genes resulting in microsatellite instability, (endogenous) sources. Many of the environmental agents and one focused on mutations in genes that are required that damage DNA have been demonstrated to be mutagens.
for chromosomal segregation resulting in chromosomal
Epidemiologic data indicate that many of these agents are also aberrations. This dichotomy may reflect only the ease by human carcinogens. The association between environmental which these manifestations can be identified. Underlying chemicals and human cancers was most definitively established both pathways may be a more general phenomenon involin situations where small groups of individuals have been ving the selection for mutator genes during tumor progresexposed to an inordinately high concentration of a specific sion. During carcinogenesis there is selection for cells chemical that elicited a rare tumor. DNA damage by chemicals harboring mutations that can overcome adverse conditions can be divided into two categories: (i) those that produce large that limit tumor growth. These mutations are produced by bulky adducts and are repaired by the nucleotide excision direct DNA damage as well as secondarily as a result of pathway; and (ii) those that cause small alterations, such as mutations in genes that cause a mutator phenotype. Thus, as alkylating agents that add methyl and ethyl groups onto tumor progression selects for cells with specific mutations, it nucleotides in DNA, and are repaired by the base excision also selects for cancer cells harboring mutations in genes repair pathway. In addition to DNA damage by environmental that normally function in maintaining genetic instability.
agents, Ames et al.
(1) have emphasized that many foods contain natural chemicals that also damage DNA and produce similar alterations. Moreover, it has been argued that consumpIntroduction tion of natural DNA-damaging chemicals from foods is much greater than our exposure to DNA-damaging chemicals proMutations are not only a hallmark of cancer but may be central to how cancers evolve. Cancer cells divide where normal cells duced by industry (2). Cellular metabolic processes also generate reactive chemical intermediates with the potential to do not; they invade, metastasize and kill the host of origin. The facts that cancer is inheritable at the cellular level and damage DNA and, as a result, might also be a source of spontaneous mutations and cancers (3). Even water has the that cancer cells contain multiple mutations, suggest that tumor progression is driven by mutagenesis. Molecular techniques potential to damage DNA, causing hydrolysis of the glycosylic bond and the formation of mutagenic abasic sites in DNA. are progressively making it easier to dissect the human genome, from chromosomes down to genes and ultimately nucleotide Based on rates of depurination of DNA in vitro, it has been estimated that each cell undergoes 10 000 depurinations per sequences. With each deeper level of exploration, more and more mutations are being documented in cancer cells. The day (4). DNA damage by reactive oxygen species has been estimated to occur at an equally high frequency (5,6), and emerging concept is that genomes of cancer cells are unstable, and this instability results in a cascade of mutations some of many of the damaged bases, such as 8-oxo-deoxyguanosine, miscode (7-9). Even though deamination of cytosine to thymidwhich enable cancer cells to bypass the host regulatory processes that control cell location, division, expression, ine is less frequent than oxidative damage to DNA (10), There is increasing evidence for the interchangeability of DNA polymerases (20) and thus mutation rates might be altered by varying the relative expression of different DNA polymerases (21) as well as by mutations that render these enzymes error-prone (22). The increase in DNA polymerase β in certain tumors suggests the possibility that polymerase β could substitute for a more accurate DNA polymerase, resulting in increased mutagenesis (23) . In Escherichia coli, DNA damage results in the induction of an error-prone response render the normal DNA polymerases error-prone. Recently, one of the proteins involved in the SOS response, UmuD' 2 C, the result is a change in nucleotide sequence in the DNA.
has been identified as an error-prone DNA polymerase that Mechanisms have evolved to repair each DNA lesion, but was designated as Pol V (25,26). Moreover, a similar errorconsidering the high frequency at which they occur and the prone DNA polymerase has been identified in yeast (27) and compact and inaccessible structure of human chromatin, it is found to be mutated in Xeroderma pigmentosum variant cells likely that a significant fraction of these lesions escape DNA (XP-V) (28, 29) . Conceivably, error-prone DNA polymerases repair and produce mutations during replication of the unreare elevated in certain cancers and contribute to the accumulapaired DNA by DNA polymerases (Figure 1 ). In general, DNA tion of DNA mutations in these tumors. polymerases copy past small alterations such as methyl or
The aforementioned results lead one to conclude that mutaethyl groups with high efficiency, and thus are likely to produce tion rates in cells are maintained at a homeostatic equilibrium mutations depending on the miscoding potential of the altered in which the extensive DNA damage is counterbalanced by nucleotide (11). Bulky adducts are not easily bypassed by multiple mechanisms for DNA repair ( Figure 1 ). In normal normal cellular polymerases and mutagenesis is dependent cells, only infrequently do lesions in DNA escape the screen on the induction of damage-inducible error-prone pathways provided for by DNA repair and direct misincorporation at the frequently involving special error-prone DNA synthesis (12).
time of DNA synthesis. In eukaryotic cells there is the emerging Taken together, these results suggest that the nucleotide concept of checkpoints in which cells sterilize the DNA sequence of cellular DNA is maintained at a homeostatic immediately prior to the onset of DNA replication (30) . equilibrium, such that an increase in the production of DNA Mutations in G 1 /S checkpoint genes allow DNA replication in damage or a reduction in DNA repair results in an increased the presence of unrepaired lesions (31) and result in enhanced frequency of mutations (Figure 1 ). mutagenesis.
Mutations arising from misincorporation by DNA polymMultiple chromosomal aberrations in many human cancers erases
Mutations can also result from nucleotide misincorporation by
One of the hallmarks of cancer cells is genetic instability. This is manifested both at the single nucleotide level, resulting in DNA polymerases in copying non-damaged DNA templates during DNA replication or even during DNA repair synthesis. point mutations, or at the chromosomal level resulting in translocations, deletions, amplifications and whole chromoStudies on the fidelity of DNA synthesis indicate that purified DNA polymerases incorporate non-complementary nucleotides some aneuploidy. Both of these forms of genetic instability can lead to a mutator phenotype via altered protein expression, at rates much greater than one would predict based on the rare spontaneous mutations in human cells. The error rates of function or gene dosage effects. There is a growing debate in the literature whether single nucleotide changes or large purified mammalian DNA polymerases in vitro thus far documented (13) vary from one in 5000 for DNA polymerase β, macromolecular chromosomal abnormalities are more prevalent in cancers or constitute a causative factor in cancer the enzyme responsible for the synthesis of short segments of DNA during repair synthesis, to one in 10 000 000 for DNA formation (32) . Aneuploidy, a change in chromosome number, is a defining characteristic of many human cancers and is one polymerases δ and ε, enzymes involved in DNA replication (14,15). The latter polymerases contain a 3Ј→5Ј exonucleolytic of the most frequent changes observed in cancer. Since each chromosome contains thousands of genes, it is amazing that activity that excises non-complementary nucleotides immediately after misincorporation by the polymerase. The frequencies changes in chromosome number are compatible with cellular viability. Specific chromosomal exchanges occur at high freof misincorporation by any DNA polymerase can vary as much as 100-fold as a result of the nucleotide sequence in quencies and are diagnostic of certain tumors. In general, there is a positive correlation between the number of chromosomal DNA (16). DNA polymerases pause at sites that have the potential to form secondary structures and these pause sites alterations within a tumor and the malignant potential of that cancer. This suggests that a progressive diminution in have been shown to be loci for enhanced misincorporation chromosome maintenance pathways leads to an increasing ally prominent in hereditary non-polyposis colon cancer (HNPCC). In this syndrome, mutation in one allele of the number of errors during carcinogenesis, and promotes the genes involved in DNA mismatch repair is inherited (41) and development of highly anaplastic tumors. Chromosomal loss of the second wild-type allele occurs with high frequency. changes visible by light microscopy must involve deletions, In other cancers that exhibit expansion or deletion of repetitive additions or translocations of DNA segments that span millions sequences, diminished DNA repair appears to be mediated by of nucleotide bases. Conceivably, these visible chromosomal methylation with reduced expression of a least one of the aberrations are the tip of an iceberg: hidden amongst these genes involved in mismatch repair (42, 43) . large rearrangements could be an even greater number of It has been assumed that the changes in the length of smaller changes in the nucleotide sequence of DNA in tumor repetitive sequences are mediated by slippage of DNA polymcells.
erases. We recently reported that damage to plasmids containing repetitive sequences by reactive oxygen species results in Cancer cells exhibit a mutator phenotype enhanced slippage specifically within the repetitive sequences The large number of chromosomal aberrations and the striking suggesting a role of oxygen free radicals in enhancing microsaheterogeneity of tumors suggest that cancer cells are genetically tellite instability (44) . In this system the preference for the unstable. Two overlapping mechanisms were initially and induction of frameshifts in microsatellite sequences by reactive independently proposed to account for this instability. First, it oxygen species is 70-fold greater than in non-repetitive was proposed that cancer cells exhibit a mutator phenotype sequences. It is now important to establish if microsatellite based on the postulate that there was an increase in the rate instability in tumors results from DNA damage by reactive of errors in DNA synthesis during tumor cell division (33) .
oxygen species. If so, this instability might then be diminished These errors could arise from mutations in DNA polymerases by drugs that scavenge reactive oxygen species; this approach that render them error-prone, or from mutations in DNA repair may be particularly relevant for tumor prevention in HNPCC proteins that render them defective. Mutations arising from families. either process would occur throughout the genome. Some of Microsatellite instability in tumors may be a harbinger for these mutations would be in additional genes normally required other types of mutations that are also present in tumors in for maintaining genetic stability. As a result, there would ensue large numbers. Tumors that exhibit microsatellite instability a cascade of mutations as tumor cells undergo successive cell frequently contain alterations in the lengths of repetitive divisions. Second, in 1976, Nowell analyzed the sequence of sequences within a variety of cancer-associated genes chromosomal aberration in tumors, and proposed a model for including: APC, IGF, TGF-β, hMSH3 and hMSH6 (39, 40) . mutation accumulation based on successive waves of clonal Tissue-culture cells defective in mismatch repair also exhibit selection (34) . Recent studies suggest the possibility that these elevations in non-selectable genes such as hgprt and oubain models are not only tightly coupled but may be interdependent resistance (45) . Nearly all breast (46) and ovarian tumors (47) (vide infra). studied utilizing comparative genomic hybridization have been shown to contain multiple changes in gene copy number. This Evidence for a mutator phenotype in human cancers technique only scores for changes that involve thousands of nucleotides. Studies using PCR-amplified gene fragments have The hypothesis that cancer cells exhibit a mutator phenotype revealed as many as 56 regions that exhibit loss of heteropredicts that by the time cancers are detected clinically, zygosity in breast cancer (48). This technique scans only a they already contain enormous numbers of mutations. Recent minute fraction of the genome and thus a much larger number evidence indeed indicates that human cancers harbor thousands of alterations are likely to be present throughout the genome. of mutations. Perhaps the earliest hint of the large number of From these data we have calculated that a tumor with 50 mutations in tumor cells were studies indicating that gene regions of loss of heterozygosity detected by PCR-amplification amplification in tumor cells accounts for the rapid emergence of a limited number of gene segments might contain as many of their resistance to the drug PALA (35) . Amplification of as 100 000 other alterations throughout the entire genome (49). resistant genes was undetectible (Ͻ10 -9 ) in primary diploid cells but was observed at frequencies as large as 10 -3 to 10 -4
Cell cycle checkpoints, apoptosis and the mutator phenotype in transformed cells derived from a variety of tumors. The Alterations in the timing of cell-cycle phases provide another extensiveness of point mutations in tumor cells was initially mechanism for the generation of a mutator phenotype. During delineated by studies on microsatellite instability in colon cell-cycle progression there are several regulatory pathways cancer. Perucho and colleagues, using arbitrary primers for that function as checkpoints and monitor the repair of damage PCR amplification, detected multiple bands at different loci of before proceeding to the next stage in the cell cycle (30) . If DNA from colon tumors but not from adjacent normal cells activated, these checkpoints function to transiently arrest cell-(36,37). Based on the changes detected in the limited number cycle progression so that damage can be repaired or that the of nucleotide sequences that were sampled, these authors proper assembly of cell components can be completed. The calculated that the tumors they examined contained more than elimination of cell-cycle checkpoints is a facile way to develop 100 000 mutations (38) . The mutations these authors observed a mutator phenotype. Mutations in p53, for example, result in were in microsatellites, repetitive nucleotide sequences located decreasing the stringency of the DNA damage checkpoint, between genes. However, it is becoming increasingly apparent allowing cancer cells to replicate damaged DNA, and to that repetitive sequences are also present within genes and accumulate mutations in daughter cells that lead to genomic also undergo expansion or contraction specifically in cancer instability (50) . In the presence of unrepairable damage, cells at very high frequencies (39, 40) . Contraction or expansion apoptosis is triggered as a final means to halting the spread of of repeats within genes provides an attractive mechanism mutations. Again, many cancers contain mutations that delay for inactivation of tumor suppressor genes during tumor or prevent the apopotic response and thus promote the survival of genetically unstable malignant cells (51). progression. High levels of microsatellite instability are especi-of the aneuploid cell lines that exhibited CIN. Since the heterozygous allele resulted in a chromosome instability phenotype, these investigators surmised that the mutation functioned in a dominant-negative manner inactivating the mitotic checkpoint. This prediction was supported by additional studies in which expression of mutant proteins was shown to alter the mitotic checkpoint in diploid cell lines.
The precise manner by which mutations in hBub1 promote aneuploidy has not been established. Bub1 was first identified along with several other mitotic checkpoint genes [Bub1-3 (56) and Mad1-3 (57)] in genetic screens for yeast genes required for pre-anaphase delay in response to spindle disruption. Additional studies suggest that Bub1 acts as a sensor that binds unattached kinetochores and delays the onset of mitosis until all chromosomes are properly attached to the mitotic spindle (58). The presence of unrepairable mitotic spindle damage normally activates a checkpoint-mediated cell-cycle expressing the Bub1 mutant proteins have a compromised mitotic checkpoint and escape the subsequent apoptosis normChromosomal instability ally induced by severe spindle damage (58). The role of apoptosis in the elimination of cells arising from a defective Aneuploidy, frequently present in many cancers, presents another manifestation of genetic instability. Some argue that mitosis is supported by studies in which the expression of Bcl-X L , an anti-apoptotic gene, is sufficient to induce polyaneuploidy is the defining characteristic of cancer and serves as the predominant mode of genetic instability, since the ploidy in a murine prolymphocytic cell line (59) . That Bub1 is essential in higher eukaryotes is supported by the fact that majority of human cancers fail to exhibit detectable microsatellite instability (38, 52) . Although aneuploidy is an easily homozygous Bub1 mutations are embryonic lethal in Drosophila (60). Cells from these larvae show severe mitotic recognized feature of cancers, little is known about its development or the selective advantage it provides for the tumor.
abnormalities including accelerated exit from metaphase, chromosome missegregation and fragmentation. Presumably, altered gene dosage enhances genetic instability and thus represents another form of the mutator phenotype.
Following a transient mitotic arrest in the presence of spindle damage, some cancer cells are able to resume the cell cycle Aneuploidy can arise from chromosomal fragmentation, translocation, amplification or non-disjunction (resulting in the by entering a second round of DNA synthesis leading to endoreduplication (two rounds of DNA synthesis without an mis-segregation of entire chromosomes). The generation of aneuploidy can be an early or even an initial event in the intervening mitosis). Cells lacking functional gene products involved in the G 1 /S checkpoint such as p53 (61,62), pRb development of genetic instability. It is conceivable that progressive increases in aneuploidy represent a predominant (62), p16 INK4A (62) or p21 Waf1/Cip1 (61,63), as well as cells that over-express myc (64) have been shown to undergo pathway for the development of genetic instability and it is independent of the accumulation of other types of mutations.
endoreduplication following a transient mitotic arrest in the presence of spindle damage. There is evidence suggesting that aneuploidy first develops from a transient tetraploid intermediate that exhibits profound Whether a mitotic checkpoint defect really plays a role in the development of aneuploidy has been questioned by two genetic instability and rapidly accumulates additional chromorecent studies. In one, no mutations were detected in five somal abnormalities (53). To achieve a tetraploid intermediate, additional mitotic checkpoint genes surveyed from the 19 one requires defective mitosis or endoreduplication: two rounds aneuploid colorectal tumors described above (65). In the other, of DNA synthesis without an intervening mitosis. For this no hBub1 mutations were detected amongst 31 head and reason and because of the presence of morphologically abnorneck carcinomas (66). However, there are many proteins that mal mitosis in tumors, many have predicted cancer cells to be participate in the segregation of chromosomes; mutations in defective in mitotic pathways. Lengauer Bub1 or Mad3L (mitotic checkpoint) in four spontaneous encompassed gains or losses of chromosomes in excess of thymic lymphomas arising in mice homozygous for Brca2 10 -2 /cell/generation. Chromosomal instability was considered truncation. These authors further showed that a dominantas a causative factor leading to aneuploidy rather than a result negative Bub1 can reverse a growth defect and initiate transof aneuploidy, since diploid cell lines that were genetically formation in mouse embryonic fibroblasts homozygous for modified to produce an aneuploid population did not exhibit the Brca truncation. These combined results suggest that chromosome instability. Fusion experiments between diploid deficiencies in the mitotic checkpoint promote chromosomal and aneuploid cell lines suggested that the molecular basis aberrations, aneuploidy and transformation, but it may occur underlying CIN is dominant. One mechanism for the developonly in cells harboring other mutations. ment of chromosomal instability is a defective mitotic checkpoint, the regulatory pathway that monitors the assembly Types of genetic instability in cancer of the mitotic spindles. In support of this hypothesis, Cahill et al. (55) identified heterozygous mutations in hBub1, a
It has been suggested that there are two major mechanisms for the generation of genetic instability (Figure 2) . One protein that participates in the mitotic checkpoint, in 5% of chromosome instability phenotype observed in cell fusion (54) suggests that modification in only one allele can result in chromosomal instability. Thus, it could be argued that a mutator phenotype is more likely to be manifested by chromosomal instability than by point mutations. However, this dichotomy may be artificial and simply reflect the relative sensitivities of both assays and the difficulties inherent in detection of random point mutations other than changes in the lengths of microsatellites. Chromosomal alterations involve millions of nucleotides and can be readily demonstrated by cytogenetic techniques. There are hundreds of thousands of microsatellites in the human genome and each target microsatellite contains many nucleotides; slippage at any single position within a repeat sequence should result in a detectable change in its length after PCR amplification and gel electrophoresis. Thus, scoring for mutations in only a few microsatellite sequences may not a clonal population of cancer cells. Methods have been developed to detect clonal mutations. However, we still lack mechanism involves mutations in DNA mismatch correction methods for quantitating random nucleotide changes in DNA genes and is manifested by microsatellite instability. The sequences in tumors, particularly when they involve only a other involves mutations in genes required for chromosomal few nucleotide substitutions. segregation and is manifested by fragmentation of chromosomes and/or duplication and deletions of whole chromosomes, Coupling of increased mutagenesis and clonal selection rather than by sequence changes involving only a few nucleotides. In the first mechanism, two allelic mutations are required Initially, two mechanisms, increased mutations and clonal selection, were invoked to account for a mutator phenotype in to generate microsatellite instability. In the second mechanism, only one mutation may be required, since the dominant nature cancer. Recent experiments in bacteria (68) and modeling studies (69) provide evidence that both mechanisms are operatrandom mutations within a cell population. New techniques ive and, moreover, intradependent. Mao et al. (68) showed are required to detect random mutations and to determine if that the spontaneous mutation rate in bacteria progressively they accumulate during tumor progression. Stratification of increases from 1/100 000 to 1/200 after four rounds of selection normal individuals based on accumulation of random mutations for mutations in different genes. Moreover, exposure to a may be predictive of the development of certain tumors. mutagen followed by subsequent rounds of selection for Stratification of tumors on the basis of accumulated mutations different mutations resulted in a population that was 100% may be predictive of malignant potential. mutators. The inference is that with each round of selection, one not only selects for a particular mutation, such as resistance Acknowledgements to rifamycin, but one also selects for mutations that increase the mutation rate throughout the genome, i.e. mutators. The rounds of clonal selection may be relevant to tumor progression. As cancers expand, they encounter a series of restrictive blockades that limits further growth. These limitations to References growth might include interference by surrounding tissues, 
